Inhibition of 5-HT3 Receptors-activated Currents by Cannabinoids in Rat Trigeminal Ganglion Neurons
- Author:
- No author available
- Issue:
- 2
- DOI:
- 10.1007/s11596-012-0047-1
- Key Word:
- WIN55,212-2;5-HT3 receptor;CB1 receptor;,CB2 receptor;trigeminal ganglion neuron;whole-cell patch clamp
Abstract： This study investigated the modulatory effect of synthetic cannbinoids WIN55,212-2 on 5-HT3 receptor-activated currents (I5-Hr3) in cultured rat trigeminal ganglion (TG) neurons using whole-cell patch clamp technique.The results showed that:(!) The majority of examined neurons (78.70％) were sensitive to 5-HT (3-300 μmol/L).5-HT induced inward currents in a concentrationdependent manner and the currents were blocked by ICS 205-930 (1 μmol/L),a selective antagonist of the 5-HT3 receptor; (2) Pre-application of WIN55,212-2 (0.01-1 μmol/L) significantly inhibited I5-HT3 reversibly in concentration-dependent and voltage-independent manners.The concentration-response curve of 5-HT3 receptor was shifted downward by WIN55,212-2 without any change of the threshold value.The EC50values of two curves were very close (17.5±4.5) μmol/L vs.(15.2±4.5) μmol/L and WIN55,212-2 decreased the maximal amplitude of I5-HI3 by (48.65±4.15)％; (3) Neither AM281,a selective CBI receptor antagonist,nor AM630,a selective CB2 receptor antagonist reversed the inhibition of I5-HT3by WIN55,212-2; (4) When WIN55,212-2 was given from 15 to 120 s before 5-HT application,inhibitory effect was gradually increased and the maximal inhibition took place at 90 s,and the inhibition remained at the same level after 90 s.We are led to concluded thatWIN55,212-2 inhibited I5-Hr3 significantly and neither CB1 receptor antagonist nor CB2 receptor antagonist could reverse the inhibition of I5-HT3 by WIN55,212-2.Moreover,WIN55,212-2 is not an open channel blocker (OCB) of 5-HT3 receptor.WIN55,212-2 significantly inhibited 5-HT-activated currents in a non-competitive manner.The inhibition of I5-HT3 by WIN55,212-2 is probably new one of peripheral analgesic mechanisms of WIN55,212-2,but the mechanism by which WIN55,212-2 inhibits I5-HT3 warrants further investigation.
- [1]胡旺平,李之望,茹立强,等.大鼠三叉神经节神经元5-羟色胺激活电流及其特征[J].2004,(6).
- [2]申晶晶,刘长金,李爱,等.大麻素抑制大鼠三叉神经节神经元ATP激活电流[J].2007,(6).
- [3]Emilia Nocerino,Marianna Amato,Angelo A Izzo.Cannabis and cannabinoid receptors[J].2000,71(1).
- [4]Hille, B,Chen, HY,Lauckner, JE,etc.GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current[J].2008,105(7).
- [5]R M Evans,K N Wease,C J MacDonald,etc.Modulation of sensory neuron potassium conductances by anandamide indicates roles for metabolites[J].2008,154(2).
- [6]S, Munro,K L, Thomas,M, Abu-Shaar.Molecular characterization of a peripheral receptor for cannabinoids.[J].1993,365(6441).
- [7]Vignali, M.,Nobile, M.,Caprini, M.,etc.The endocannabinoid anandamide inhibits potassium conductance in rat cortical astrocytes[J].2009,57(7).
- [8]石丽君,刘玲爱,程晓红,等.糖皮质激素对神经元烟碱受体的调制作用[J].2002,(3).
- [9]Herkenham M,Hohmann AG.Localization of central cannabinoid CB1 receptor messenger RNA in neuronal subpopulations of rat dorsal root ganglia: a double-label in situ hybridization study.[J].1999,90(3).
- [10]Osibow K,Zoratti C,Malli R,etc.Integrin clustering enables anandamide-induced Ca2+ signaling in endothelial cells via GPR55 by protection against CB1-receptor-triggered repression.[J].2008,121(Pt.10).
- [11]Patel S,James I,Kesingland A,etc.The role of central and peripheral Cannabinoid1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain.[J].2001,92(1).
- [12]Ross RA,Pertwee RG.Cannabinoid receptors and their ligands.[J].2002,66(2).
- [13]B F, Thomas,D R, Compton,B R, Martin.Characterization of the lipophilicity of natural and synthetic analogs of delta 9-tetrahydrocannabinol and its relationship to pharmacological potency.[J].1990,255(2).
- [14]Howlett AC,Childers SR,Deadwyler SA,etc.Cannabinoid physiology and pharmacology: 30 years of progress.[J].2004,47(Suppl.1).
- [15]Martin, W. J.,Coffin, P. O.,Attias, E.,etc.Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections[J].1999,822(1).
- [16]Silvio Mazzari,Roberto Canella,Lucia Petrelli,etc.N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation[J].1996,300(3).
- [17]Vanegas H,Schaible HG.Prostaglandins and cyclooxygenases (correction of cycloxygenases) in the spinal cord.[J].2001,64(4).
- [18]Johanek LM,Turner M,Hodges J,etc.Cannabinoids attenuate capsaicin-evoked hyperalgesia through spinal and peripheral mechanisms.[J].2001,93(3).
- [19]Fan P.Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons.[J].1995,73(2).
- [20]Murat, Oz,Li, Zhang,Marisela, Morales.Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.[J].2002,46(3).